Chapter 038

Principles of Antibiotic Therapy1

Thomas J. Pallasch

CITED REFERENCES

  1. Aarestrup FM, Agerso LY, Ahrens P, et al: Antimicrobial susceptibility and presence of resistance genes in staphylococci from poultry. Vet Microbiol 74:353-364, 2000. PUBMED Abstract
  2. Abouesh A, Stone C, Hobbs WR: Antimicrobial-induced mania (antibiomania): a review of spontaneous reports. J Clin Psychopharmacol 22:71-81, 2002. PUBMED Abstract
  3. Acar JF: Antibiotic synergy and antagonism. Med Clin North Am 84:1391-1406, 2000. PUBMED Abstract
  4. Ahmad M, Urban C, Mariano N, et al: Clinical characteristics and molecular epidemiology associated with imipenem-resistant Klebsiella pneumoniae. Clin Infect Dis 29:352-355, 1999. PUBMED Abstract
  5. Ambrose PG Jr, Owens RC, Grasela D: Antimicrobial pharmacodynamics. Med Clin North Am 84:1431-1446, 2000. PUBMED Abstract
  6. Barbosa TM, Levy SB: The impact of antibiotic use on resistance development and persistence. Drug Resist Update 3:303-311, 2000. PUBMED Abstract
  7. Barkay T, Smets BF: Horizontal gene flow in microbial communities. Nat Rev Microbiol 3:675-687, 2005.
  8. Bennett PM: Plasmid encoded antibiotic resistance: acquisition and transfer of antibiotic resistance genes in bacteria. Br J Pharmacol 153:S347-S357, 2008. PUBMED Abstract
  9. Bouza E, Munoz P: Monotherapy versus combination therapy for bacterial infections. Med Clin North Am 84:1357-1389, 2000. PUBMED Abstract
  10. Breithaupt H: The new antibiotics: can novel antibacterial treatments combat the rising tide of drug resistant infections? Nat Biotechnol 17:1165-1169, 1999.
  11. Bush K: New β-lactamases in gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy. Clin Infect Dis 32:1085-1089, 2001. PUBMED Abstract
  12. Butler DR, Kuhn RJ, Chandler MH: Pharmacokinetics of anti-infective agents in paediatric patients. Clin Pharmacokinet 26:374-395, 1994. PUBMED Abstract
  13. Canton R, Coque TM: The CTX-M beta-lactamase pandemic. Curr Opin Microbiol 9:466-475, 2006. PUBMED Abstract
  14. Cetinkaya Y, Falk P, Mayhall CG: Vancomycin-resistant enterococci. Clin Microbiol Rev 13:686-707, 2000. PUBMED Abstract
  15. Chadwick PR, Wooster SL: Glycopeptide resistance in Staphylococcus aureus. J Infect 40:211-217, 2000. PUBMED Abstract
  16. Chen X, Schauder S, Potier N, et al: Structural identification of a quorum-sensing signal containing boron. Nature 415:545-549, 2002. PUBMED Abstract
  17. Chopra I, Roberts M: Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol Mol Biol Rev 65:232-260, 2001. PUBMED Abstract
  18. Cleveland JL, Kohn WC: Antimicrobial resistance and dental care: a CDC perspective. Dent Abstr 43:108-110, 1998.
  19. Cohen ML: Changing patterns of infectious disease. Nature 406:762-767, 2000. PUBMED Abstract
  20. Craig WA: Pharmacokinetic/pharmacodynamic parameters: rationale for antimicrobial dosing in mice and men. Clin Infect Dis 26:1-10, 1998. PUBMED Abstract
  21. Cunha BA, Ortega AM: Antibiotic failures. Med Clin North Am 79:663-672, 1995. PUBMED Abstract
  22. Cunney RJ, Smith EG: The impact of laboratory reporting practice on antibiotic utilization. J Int Antimicrob Agents 14:13-19, 2000. PUBMED Abstract
  23. Deragon JM, Capy P: Impact of transposable elements on the human genome. Ann Med 32:264-273, 2000. PUBMED Abstract
  24. Donnenberg MS: Pathogenic strategies of enteric bacteria. Nature 406:768-774, 2000. PUBMED Abstract
  25. Dore MP, Leandro G, Realdi G, et al: Effect of pretreatment antibiotic resistance to metronidazole and clarithromycin on outcome of Helicobacter pylori therapy: a meta-analytical approach. Dig Dis Sci 45:68-76, 2000. PUBMED Abstract
  26. Doucet-Populaire F, Trieu-Cuot P, Dosbaa I, et al: Inducible transfer of conjugative transposons Tn/1545 from Enterococcus faecalis to Listeria monocytogenes in the digestive tracts of gnotobiotic mice. Antimicrob Agents Chemother 35:185-187, 1991. PUBMED Abstract
  27. Epstein JB, Chong S, Le ND: A survey of antibiotic use in dentistry. J Am Dent Assoc 131:1600-1609, 2000. PUBMED Abstract
  28. Estes L: Review of pharmacokinetics and pharmacodynamics of antimicrobial agents. Mayo Clin Proc 73:1114-1122, 1998. PUBMED Abstract
  29. Fuursted K: Postantibiotic effects in vitro. APMIS Suppl 90:1-23, 1999. PUBMED Abstract
  30. Gebreyes WA, Davies PR, Morrow WEM, et al: Antimicrobial resistance of Salmonella isolates from swine. J Clin Microbiol 38:4633-4636, 2000. PUBMED Abstract
  31. Greene VW: Personal hygiene and life expectancy improvements since 1850: historic and epidemiologic associations. Am J Infect Control 29:203-206, 2001. PUBMED Abstract
  32. Guillemot D, Carbon C, Balkau B, et al: Low dosage and long treatment duration of β-lactam: risk factors for carriage of penicillin-resistant Streptococcus pneumoniae. JAMA 279:365-370, 1998. PUBMED Abstract
  33. Heimdahl A: Culturing the exudate of an odontogenic infection: a useful procedure? [letter]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 90:2-4, 2000. PUBMED Abstract
  34. Heimdahl A, Nord CE: Influence of doxycycline on the normal human flora and colonization of the oral cavity and colon. Scand J Infect Dis 15:293-302, 1983. PUBMED Abstract
  35. Henry NK, Hoecker JL, Rhodes KH: Antimicrobial therapy for infants and children: guidelines for the inpatient and outpatient practice of pediatric infectious diseases. Mayo Clin Proc 75:86-97, 2000. PUBMED Abstract
  36. Hentschel U, Hacker J: Pathogenicity islands: the tip of the iceberg. Microbes Infect 3:545-548, 2001. PUBMED Abstract
  37. Hirschhorn LR, Trnka Y, Onderdonk A, et al: Epidemiology of community-acquired Clostridium difficile-associated diarrhea. J Clin Infect Dis 169:127-133, 1994. PUBMED Abstract
  38. Hoban DJ, Doern GV, Fluit AC, et al: Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis 32(Suppl 2):S81-S93, 2001. PUBMED Abstract
  39. Jacobs MR, Applebaum PC, Zhanel GG, et al: Authors reply: assumed versus approved breakpoints. Antimicrob Agents Chemother 44:3243-3245, 2000. PUBMED Abstract
  40. Jorgensen JH: Who defines resistance? The clinical and economic impact of antimicrobial susceptibility testing breaking points. Semin Pediatr Infect Dis 15:105-108, 2004. PUBMED Abstract
  41. Jorgensen JH, Ferraro ML: Antimicrobial susceptibility testing: general principles and contemporary practices. Clin Infect Dis 26:973-980, 1998. PUBMED Abstract
  42. Kopeloff N: Why infections? London, 1926, Alfred A Knopf.
  43. Kresse K, Belsy MJ, Rovini H: The antibacterial drugs market. Nat Rev Drug Discov 6:19-20, 2007. PUBMED Abstract
  44. Kunin CM: Dosage schedules of antimicrobial agents: a historical review. Rev Infect Dis 3:4-11, 1981. PUBMED Abstract
  45. Kunin CM: Editorial response: antibiotic Armageddon. Clin Infect Dis 25:240-241, 1997. PUBMED Abstract
  46. Labro M-T: Interference of antibacterial agents with phagocyte functions: immunomodulation or “immuno-fairy tales”? Clin Microbiol Rev 13:615-650, 2000. PUBMED Abstract
  47. Lederberg J: Infectious history. Science 288:287-293, 2000. PUBMED Abstract
  48. Leistevuo J, Järvinen H, Österblad M, et al: Resistance to mercury and antimicrobial agents in Streptococcus mutans isolates from human subjects in relation to exposure to dental amalgam fillings. Antimicrob Agents Chemother 44:456-457, 2000. PUBMED Abstract
  49. Levison ME: Pharmacodynamics of antibacterial drugs. Infect Dis Clin North Am 14:281-291, 2000. PUBMED Abstract
  50. Levy SB: The antibiotic paradox, New York, 1992, Plenum Press.
  51. Livornese LL Jr, Slavin D, Benz RL, et al: Use of antibacterial agents in renal failure. Infect Dis Clin North Am 14:371-390, 2000. PUBMED Abstract
  52. Low DE, Keller N, Barth A, et al: Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns to enterococci: results from the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis 32(Suppl 2):S133-S145, 2001. PUBMED Abstract
  53. Low DE, Kellner JD, Wright GD: Superbugs: how they evolve and minimize the cost of resistance. Infect Dis Rep 1:464-469, 1999. PUBMED Abstract
  54. Maggiolo F, Puricelli G, Dottorini M, et al: The effect of ciprofloxacin on oral contraceptive steroid treatments. Drug Exp Clin Res 17:451-454, 1991. PUBMED Abstract
  55. Manie T, Khan S, Brozel VS, et al: Antimicrobial resistance of bacteria isolated from slaughtered and retail chickens in South Africa. Lett Appl Microbiol 26:253-258, 1998. PUBMED Abstract
  56. Martin MV, Longman LP, Hill JB, et al: Acute dentoalveolar infections: an investigation of the duration of antibiotic therapy. Br Dent J 183:135-137, 1997. PUBMED Abstract
  57. McCabe RM, Kreger DE, Johns M: Type-specific and cross-reactive antibodies in gram-negative bacteremia. N Engl J Med 287:261-267, 1977. PUBMED Abstract
  58. Miller YW, Eady EA, Lacey RW, et al: Sequential antibiotic therapy for acne promotes the carriage of resistant staphylococci on the skin of contacts. J Antimicrob Chemother 38:829-837, 1996. PUBMED Abstract
  59. Miriagov V, Carattoli A, Fanning S: Antimicrobial resistance islands: resistance gene clusters in Salmonella chromosomes and plasmids. Microbiol Infection 8:1923-1930, 2006. PUBMED Abstract
  60. Monaghan RL, Barrett JF: Antibacterial drug discovery—then, now and the genomic future. Biochem Pharmacol 71:901-909, 2006. PUBMED Abstract
  61. Murphy AA, Zachur HA, Charache P, et al: The effect of tetracycline on levels of oral contraceptives. Am J Obstet Gynecol 164:28-33, 1991. PUBMED Abstract
  62. Neely JL, Abate M, Swinker M, et al: The effect of doxycycline on serum levels of ethinyl estradiol, norethindrone, and endogenous progesterone. Obstet Gynecol 77:416-420, 1991. PUBMED Abstract
  63. Neu HC: Current practices in antimicrobial dosing. Rev Infect Dis 3:12-18, 1981. PUBMED Abstract
  64. Nguyen TN, Phan QG, Duong LP, et al: Effects of carriage and expression of the Tn10 tetracycline resistance operon on the fitness of Escherichia coli K12. Molec Biol Evol 6:213-225, 1989. PUBMED Abstract
  65. Novak R, Henriques B, Charpentier E, et al: Emergence of vancomycin tolerance in Streptococcus pneumoniae. Nature 399:590-593, 1999. PUBMED Abstract
  66. Osterblad M, Leistevuo J, Leistevuo T, et al: Antimicrobial and mercury resistance in aerobic gram-negative bacilli in fecal flora among persons with and without dental amalgam fillings. Antimicrob Agents Chemother 39:2499-2502, 1995. PUBMED Abstract
  67. Pallasch TJ: How to use antibiotics effectively. J Calif Dent Assoc 21:46-50, 1993. PUBMED Abstract
  68. Pallasch TJ: Clostridium difficile-associated diarrhea and colitis. J Calif Dent Assoc 27:405-413, 1999. PUBMED Abstract
  69. Pallasch TJ: Global antibiotic resistance and its impact on the dental community. J Calif Dent Assoc 28:215-233, 2000. PUBMED Abstract
  70. Pallasch TJ: Pharmacokinetic principles of antimicrobial therapy. Perio 2000 10:5-11, 1996. PUBMED Abstract
  71. Pallasch TJ, Gill CJ: Microbial resistance to antibiotics. J Calif Dent Assoc 14:25-27, 1986.
  72. Pallasch TJ, Slots J: Oral microorganisms and cardiovascular disease. J Calif Dent Assoc 28:204-214, 2000. PUBMED Abstract
  73. Pallasch TJ, Wahl MJ: Focal infection: new age or ancient history? Endod Topics 4:32-45, 2003.
  74. Palmer NO, Martin MV, Pealing R, et al: An analysis of antibiotic prescriptions from general dentist practitioners in England. J Antimicrob Chemother 46:1033-1035, 2000. PUBMED Abstract
  75. Payne DJ, Gwynn MN, Holmes DJ, et al: Drugs for bad bugs: confronting the challenge of antibacterial discovery. Nat Rev Drug Discov 6:29-40, 2007. PUBMED Abstract
  76. Petrocheilou V, Richmond MH, Bennett PM: The persistence of R-plasmid-carrying E. coli in a married couple, one of whom was receiving antibiotics. Contrib Microbiol Immunol 6:178-188, 1979. PUBMED Abstract
  77. Pfaller MA, Segreti J: Overview of the epidemiological profile and laboratory detection of extended-spectrum beta-lactamases. Clin Infect Dis 42:S153-S163, 2006. PUBMED Abstract
  78. Phillips A: Will the drugs still work? Transmission of resistant HIV. Nat Med 7:993-994, 2001. PUBMED Abstract
  79. Ploy MC, Lambert T, Couty J-P, et al: Integrons: an antibiotic resistance gene capture and expression system. Clin Chem Lab Med 38:483-487, 2000. PUBMED Abstract
  80. Polk R: Optimal use of modern antibiotics: emerging trends. Clin Infect Dis 29:264-274, 1999. PUBMED Abstract
  81. Putman M, vanVeen HW, Konings WN: Molecular properties of bacterial multidrug transporters. Microbiol Mol Biol Rev 64:672-693, 2000. PUBMED Abstract
  82. Rice LB, Bonomo RA: The red menace: emerging issues in antimicrobial resistance in gram-negative bacilli. Curr Infect Dis Rep 1:338-346, 1999. PUBMED Abstract
  83. Roberts AP, Pratten J, Wilson M, et al: Transfer of a conjugative transposon, Tn 5397 in a model oral biofilm. FEMS Microbiol Lett 177:63-66, 1999. PUBMED Abstract
  84. Roberts MC, Sutcliffe J, Courvalin P, et al: Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants. Antimicrob Agents Chemother 43:2823-2830, 1999. PUBMED Abstract
  85. Ryan DM, Cars O, Hoffstedt B: The use of antibiotic serum levels to predict concentrations in tissues. Scand J Infect Dis 18:381-388, 1986. PUBMED Abstract
  86. Saenz Y, Zarazaga M, Lantero M, et al: Antibiotic resistance in Campylobacter strains isolated from animals, foods, and humans in Spain in 1997-1998. Antimicrob Agents Chemother 44:267-271, 2000. PUBMED Abstract
  87. Salyers AA, Shoemaker NB, Li LY: In the driver’s seat: the Bacteroides conjugative transposons and the elements they mobilize. J Bacteriol 177:5727-5731, 1995. PUBMED Abstract
  88. Salyers AA, Whitt DD: Bacterial pathogenesis: a molecular approach, ed 2, Washington, DC, 2002, ASM Press.
  89. Schrag SJ, Beall B, Dowell SF: Limiting the spread of resistant pneumococci: biological and epidemiologic evidence for the effectiveness of alternative interventions. Clin Microbiol Rev 13:588-601, 2000. PUBMED Abstract
  90. Scott G: Prevention and control of infections in intensive care. Intensive Care Med 26(Suppl 1):S22-S25, 2000. PUBMED Abstract
  91. Scott MG, Hancock RE: Cationic antimicrobial peptides and their multifunctional role in the immune system. Crit Rev Immunol 20:407-431, 2000. PUBMED Abstract
  92. Shaffer D, Singer S, Korvick J: Macrolide and fluoroquinolone associated torsades de pointes: review of the FDA Adverse Event Reporting System, 41st Annual ICAAC Meeting, A-635, Chicago, December 2000.
  93. Shoemaker NB, Vlamakis H, Hayes K, et al: Evidence for extensive resistance gene transfer among Bacteroides spp. and among Bacteroides and other genera in the human colon. Appl Environ Microbiol 67:561-568, 2001. PUBMED Abstract
  94. Showsh SA, Andrews RE Jr: Tetracycline enhances Tn916-mediated conjugal transfer. Plasmid 28:213-214, 1992. PUBMED Abstract
  95. Smets BF, Barkay T: Horizontal gene transfer: perspectives at a crossroads of scientific disciplines. Nat Rev Microbiol 3:675-687, 2005. PUBMED Abstract
  96. Smith H: Host factors that influence the behavior of bacteria pathogens in vivo. Int J Med Microbiol 290:207-213, 2000. PUBMED Abstract
  97. Smith R: Action on antimicrobial resistance: not easy but Europe can do it. BMJ 317:764, 1998. PUBMED Abstract
  98. Spratt BG: Antibiotic resistance: counting the cost. Curr Biol 6:1219-1221, 1996. PUBMED Abstract
  99. Stephenson J: “Sobering” levels of drug-resistant HIV found. JAMA 287:704-705, 2002. PUBMED Abstract
  100. Stergachis A, Perera DR, Schnell MM, et al: Antibiotic-associated colitis. West J Med 140:217-219, 1984. PUBMED Abstract
  101. Stevens AM, Sanders JM, Shoemaker NB, et al: Genes involved in production of plasmidlike forms by a Bacteroides conjugal chromosomal element share amino acid homology with two-component regulatory systems. J Bacteriol 174:2935-2942, 1992. PUBMED Abstract
  102. Stevens AM, Shoemaker NB, Li LY, et al: Tetracycline regulation of genes on Bacteroides conjugative transposons. J Bacteriol 175:6134-6141, 1993. PUBMED Abstract
  103. Summers AO, Wireman J, Vimy MJ, et al: Mercury released from dental “silver” fillings provokes an increase in mercury- and antibiotic-resistant bacteria in oral and intestinal floras of primates. Antimicrob Agents Chemother 37:825-834, 1993. PUBMED Abstract
  104. Tancrede C, Barakat R: Ecological impact of low doses of oxytetracycline on human intestinal microflora. J Vet Med 42:35-39, 1989.
  105. Tatro DS: Drug-induced prolongation of the QT interval and torsades de pointes. Drug Facts and Comparison News Sept:67-70, 2001.
  106. Thomas J, Walker C, Bradshaw M: Long-term use of subantimicrobial dose doxycycline does not lead to changes in antimicrobial susceptibility. J Periodontol 71:1472-1483, 2000. PUBMED Abstract
  107. Thomas JK, Forrest A, Bhavnani SM, et al: Pharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapy. Antimicrob Agents Chemother 42:521-527, 1998. PUBMED Abstract
  108. Thompson RL, Wright AJ: General principles of antimicrobial therapy. Mayo Clin Proc 73:995-1006, 1998. PUBMED Abstract
  109. Torres OR, Korman RZ, Zahler SA, et al: The conjugative transposon Tn925: enhancement of conjugal transfer by tetracycline in Enterococcus faecalis and mobilization of chromosomal genes in Bacillus subtilis and E. faecalis. Mol Gen Genet 225:395-400, 1991. PUBMED Abstract
  110. Van Bambeke F, Balzi E, Tulkens PM: Antibiotic efflux pumps. Biochem Pharmacol 60:457-470, 2000. PUBMED Abstract
  111. van den Bogaard AE, London N, Stobberingh EE: Antimicrobial resistance in pig faecal samples from The Netherlands (five abattoirs) and Sweden. J Antimicrob Chemother 45:663-671, 2000. PUBMED Abstract
  112. Wagenlehner F, Stower-Hoffman J, Schneider-Brachert W, et al: Influence of a prophylactic single dose of ciprofloxacin on the level of resistance of Escherichia coli to fluoroquinolones in urology. Int J Antimicrob Agents 15:207-211, 2000. PUBMED Abstract
  113. Walton RE: Culturing the exudate of an odontogenic infection: a useful procedure? [editorial]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 88:525, 1999. PUBMED Abstract
  114. Wenzel RP, Edmond MB: The impact of hospital-acquired bloodstream infections. Emerg Infect Dis 7:174-177, 2001. PUBMED Abstract
  115. White MC: Mortality associated with nosocomial infections: analysis of multiple cause-of-death data. J Clin Epidemiol 46:95-100, 1993. PUBMED Abstract
  116. Wilkowske CJ: General principles of antimicrobial therapy. Mayo Clin Proc 66:931-941, 1991. PUBMED Abstract
  117. Wireman J, Liebert CA, Smith T, et al: Association of mercury resistance with antibiotic resistance in gram-negative fecal bacteria of primates. Appl Environ Microbiol 63:4494-4503, 1997. PUBMED Abstract
  118. Woods AC: Focal infection. Am J Ophthalmol 25:1423-1444, 1942.
  119. Yingling NM, Byrne BE, Hartwell GR: Antibiotic use by members of the American Association of Endodontists in the year 2000: report of a national survey. J Endod 28:396-404, 2002. PUBMED Abstract
  120. Zasloff M: Antimicrobial peptides of multicellular organisms. Nature 415:389-395, 2002. PUBMED Abstract

GENERAL REFERENCES

  1. Duncan MJ: Oral microbiology and genomics, Periodontol 2000 38:63-71, 2005. PUBMED Abstract
  2. Haffajee AD, Socransky SS: Introduction to microbial aspects of periodontal biofilm communities, development and treatment, Periodontol 2000 42:7-12, 2006. PUBMED Abstract
  3. Kolenbrander PE, Palmer RJ Jr, Rickard AH, et al: Bacterial interactions and successions during plaque development, Periodontol 2000 42:47-79, 2006. PUBMED Abstract
  4. Socransky SS, Haffajee AD: Periodontal microbial ecology, Periodontol 2000 38:135-187, 2005. PUBMED Abstract
  5. Taubman MA, Nash DA: The scientific and public-health imperative for a vaccine against dental caries, Nat Rev Immunol 6:555-563, 2006. PUBMED Abstract

1The author recognizes Dr. Edward Montgomery for his past contributions to this chapter.